Saito, N.; Nishiofuku, H.; Sato, T.; Maeda, S.; Minamiguchi, K.; Taiji, R.; Matsumoto, T.; Chanoki, Y.; Tachiiri, T.; Kunichika, H.;
et al. Predictive Factors of Complete Response to Transarterial Chemoembolization in Intermediate Stage Hepatocellular Carcinoma beyond Up-To-7 Criteria. Cancers 2023, 15, 2609.
https://doi.org/10.3390/cancers15092609
AMA Style
Saito N, Nishiofuku H, Sato T, Maeda S, Minamiguchi K, Taiji R, Matsumoto T, Chanoki Y, Tachiiri T, Kunichika H,
et al. Predictive Factors of Complete Response to Transarterial Chemoembolization in Intermediate Stage Hepatocellular Carcinoma beyond Up-To-7 Criteria. Cancers. 2023; 15(9):2609.
https://doi.org/10.3390/cancers15092609
Chicago/Turabian Style
Saito, Natsuhiko, Hideyuki Nishiofuku, Takeshi Sato, Shinsaku Maeda, Kiyoyuki Minamiguchi, Ryosuke Taiji, Takeshi Matsumoto, Yuto Chanoki, Tetsuya Tachiiri, Hideki Kunichika,
and et al. 2023. "Predictive Factors of Complete Response to Transarterial Chemoembolization in Intermediate Stage Hepatocellular Carcinoma beyond Up-To-7 Criteria" Cancers 15, no. 9: 2609.
https://doi.org/10.3390/cancers15092609
APA Style
Saito, N., Nishiofuku, H., Sato, T., Maeda, S., Minamiguchi, K., Taiji, R., Matsumoto, T., Chanoki, Y., Tachiiri, T., Kunichika, H., Marugami, N., & Tanaka, T.
(2023). Predictive Factors of Complete Response to Transarterial Chemoembolization in Intermediate Stage Hepatocellular Carcinoma beyond Up-To-7 Criteria. Cancers, 15(9), 2609.
https://doi.org/10.3390/cancers15092609
